ATE303403T1 - Modifizierte rekombinase - Google Patents

Modifizierte rekombinase

Info

Publication number
ATE303403T1
ATE303403T1 AT01993622T AT01993622T ATE303403T1 AT E303403 T1 ATE303403 T1 AT E303403T1 AT 01993622 T AT01993622 T AT 01993622T AT 01993622 T AT01993622 T AT 01993622T AT E303403 T1 ATE303403 T1 AT E303403T1
Authority
AT
Austria
Prior art keywords
recombinase
fusion protein
genome
cell
site
Prior art date
Application number
AT01993622T
Other languages
English (en)
Inventor
Ralf Kuehn
Susanne Felder
Frieder Schwenk
Birgit Kueter-Luks
Nicole Faust
Original Assignee
Artemis Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00124629A external-priority patent/EP1205490A1/de
Application filed by Artemis Pharmaceuticals Gmbh filed Critical Artemis Pharmaceuticals Gmbh
Application granted granted Critical
Publication of ATE303403T1 publication Critical patent/ATE303403T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Dairy Products (AREA)
AT01993622T 2000-11-10 2001-11-09 Modifizierte rekombinase ATE303403T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00124629A EP1205490A1 (de) 2000-11-10 2000-11-10 Fusionsprotein, das eine Integrase (phiC31) und ein Signalpeptid (NLS) enthält
EP01109543 2001-04-17
US31187601P 2001-08-13 2001-08-13
PCT/EP2001/012975 WO2002038613A2 (en) 2000-11-10 2001-11-09 Modified recombinase

Publications (1)

Publication Number Publication Date
ATE303403T1 true ATE303403T1 (de) 2005-09-15

Family

ID=56290218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01993622T ATE303403T1 (de) 2000-11-10 2001-11-09 Modifizierte rekombinase

Country Status (5)

Country Link
EP (1) EP1395612B1 (de)
AT (1) ATE303403T1 (de)
AU (1) AU2002221829A1 (de)
DE (1) DE60113159T2 (de)
WO (1) WO2002038613A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2355493T3 (es) * 2000-02-18 2011-03-28 The Board Of Trustees Of The Leland Stanford Junior University Recombinasas alteradas para la modificación del genoma.
WO2003066867A2 (en) * 2002-02-06 2003-08-14 Artemis Pharmaceuticals Gmbh Genetically engineered phic31-integrase genes
DE10207313A1 (de) * 2002-02-21 2003-09-11 Vision 7 Gmbh Verfahren zur ortsspezifischen DNA-Rekombination
EP1439234A1 (de) * 2003-01-08 2004-07-21 ARTEMIS Pharmaceuticals GmbH Gezielte Transgenese unter Verwendung des rosa26-Lokus
EP1483962A3 (de) * 2003-06-06 2005-01-12 F. Hoffmann-La Roche Ag Transgenes Tiermodel für Glyt1 Funktion
US9034650B2 (en) 2005-02-02 2015-05-19 Intrexon Corporation Site-specific serine recombinases and methods of their use
NZ572884A (en) * 2006-05-22 2011-12-22 Hiprocell Llc Transformation of eukaryotic cells using two different recombination sites recognised by two different unidirectional site-specific recombinases
CN100410369C (zh) * 2006-06-22 2008-08-13 复旦大学 经tat和nls多肽修饰的φc31整合酶蛋白及其应用
EP2115136A4 (de) * 2006-12-21 2010-05-19 Glaxosmithkline Llc Neuartige verfahren

Also Published As

Publication number Publication date
DE60113159D1 (de) 2005-10-06
AU2002221829A1 (en) 2002-05-21
DE60113159T2 (de) 2006-07-06
WO2002038613A3 (en) 2004-01-08
EP1395612A2 (de) 2004-03-10
EP1395612B1 (de) 2005-08-31
WO2002038613A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
Hoess et al. The Cre-lox recombination system
CN102787125B (zh) 一种构建tale重复序列的方法
RU2004107694A (ru) Способ интеграции генов в специфических сайтах в клетках млекопитающих посредством гомологичной рекомбинации и векторы для осуществления этого способа
DE60143564D1 (de) Veränderte rekombinasen zur modifizierung des genoms
US8796183B2 (en) Template fixed beta-hairpin loop mimetics and their use in phage display
ATE222289T1 (de) Rekombinatorische klonierung in vitro unter verwendung genmanipulierter rekombinationsorte
ATE204298T1 (de) Hybrider mensch/tier faktor viii
DE60113159D1 (de) Modifizierte rekombinase
ATE469231T1 (de) Von rna-virus abgeleitetes pflanzenexpressionssystem
EA199900503A1 (ru) Днк, кодирующая активные дельта-эндотоксины чешуекрылых насекомых, и ее использование
ES2167304T3 (es) Peptido que contiene el antigeno de superficie de la hepatitis b.
ATE369384T1 (de) Expression und export von interferon-alpha proteinen als fc fusionsproteine
CN107109422A (zh) 使用由两个载体表达的Cas9蛋白质调节基因表达的方法
WO2002014495A3 (en) Enhanced homologous recombination mediated by lambda recombination proteins
ATE423213T1 (de) Erhöhte expression in pflanzen durch verwendung von nicht-translierter leader-sequenz
ATE443074T1 (de) Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
EA199800324A1 (ru) Улучшенное встраивание экзогенной днк, введенной в эукариостические клетки
CN119614632B (zh) 一种优化的NlovFz2-ωRNA编辑系统
JP2023515670A (ja) キロ塩基スケールでのｒｎａガイドゲノムリコンビニアリング
DE69932446D1 (de) Verfahren zur herstellung von nukleinsäure- und polypeptidbanken durch in vivo rekombination und ihre verwendungen
DE60144021D1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
Osawa et al. Evolution of life: fossils, molecules and culture
CN107312788B (zh) 一种tale重复序列载体的构建方法
ATE259421T1 (de) Dna-virus-vektoren und verfahren zu ihrer herstellung
DK0915165T3 (da) Fremgangsmåde til hjælper-virusfri pakning af et genvektor-DNA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties